• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

整合素靶向磁共振成像。

Integrin Targeted MR Imaging.

机构信息

Department of Biomedical Engineering, Case Western Reserve University, Cleveland, OH 44106, USA.

出版信息

Theranostics. 2011 Jan 19;1:83-101. doi: 10.7150/thno/v01p0083.

DOI:10.7150/thno/v01p0083
PMID:21547154
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3086609/
Abstract

Magnetic resonance imaging (MRI) is a powerful medical diagnostic imaging modality for integrin targeted imaging, which uses the magnetic resonance of tissue water protons to display tissue anatomic structures with high spatial resolution. Contrast agents are often used in MRI to highlight specific regions of the body and make them easier to visualize. There are four main classes of MRI contrast agents based on their different contrast mechanisms, including T(1), T(2), chemical exchange saturation transfer (CEST) agents, and heteronuclear contrast agents. Integrins are an important family of heterodimeric transmembrane glycoproteins that function as mediators of cell-cell and cell-extracellular matrix interactions. The overexpressed integrins can be used as the molecular targets for designing suitable integrin targeted contrast agents for MR molecular imaging. Integrin targeted contrast agent includes a targeting agent specific to a target integrin, a paramagnetic agent and a linker connecting the targeting agent with the paramagnetic agent. Proper selection of targeting agents is critical for targeted MRI contrast agents to effectively bind to integrins for in vivo imaging. An ideal integrin targeted MR contrast agent should be non-toxic, provide strong contrast enhancement at the target sites and can be completely excreted from the body after MR imaging. An overview of integrin targeted MR contrast agents based on small molecular and macromolecular Gd(III) complexes, lipid nanoparticles and superparamagnetic nanoparticles is provided for MR molecular imaging. By using proper delivery systems for loading sufficient Gd(III) chelates or superparamagnetic nanoparticles, effective molecular imaging of integrins with MRI has been demonstrated in animal models.

摘要

磁共振成像(MRI)是一种强大的医学诊断成像方式,用于整合素靶向成像,它利用组织水质子的磁共振来显示具有高空间分辨率的组织解剖结构。对比剂通常用于 MRI 中突出身体的特定区域,使其更容易可视化。根据不同的对比机制,MRI 对比剂主要有四类,包括 T(1)、T(2)、化学交换饱和转移(CEST)试剂和异核对比剂。整合素是异二聚体跨膜糖蛋白家族,作为细胞-细胞和细胞-细胞外基质相互作用的介质。过度表达的整合素可以作为设计合适的整合素靶向对比剂用于 MR 分子成像的分子靶点。整合素靶向对比剂包括针对靶整合素的靶向剂、顺磁剂和连接靶向剂与顺磁剂的接头。靶向剂的适当选择对于靶向 MRI 对比剂有效地与整合素结合以进行体内成像至关重要。理想的整合素靶向 MR 对比剂应该是无毒的,在靶位提供强烈的对比增强,并且在 MR 成像后可以完全从体内排出。本文概述了基于小分子和大分子 Gd(III)配合物、脂质纳米粒和超顺磁纳米粒的整合素靶向 MR 对比剂,用于 MR 分子成像。通过使用适当的递送系统来装载足够的 Gd(III)螯合物或超顺磁纳米粒,已经在动物模型中证明了使用 MRI 对整合素进行有效的分子成像。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe7/3086609/e86972ac3845/thnov01p0083g24.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe7/3086609/535af52cb334/thnov01p0083g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe7/3086609/a930c8c6aab5/thnov01p0083g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe7/3086609/920be62ef5e5/thnov01p0083g06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe7/3086609/b697c2fbeac5/thnov01p0083g07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe7/3086609/345d914f8917/thnov01p0083g08.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe7/3086609/10499b4329e5/thnov01p0083g10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe7/3086609/9116ed0112fb/thnov01p0083g11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe7/3086609/da8090bc2356/thnov01p0083g12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe7/3086609/173b47df7d43/thnov01p0083g13.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe7/3086609/175b37ebf61a/thnov01p0083g14.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe7/3086609/5cbcc397ecac/thnov01p0083g15.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe7/3086609/499584d2d301/thnov01p0083g16.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe7/3086609/11d0ead164e8/thnov01p0083g17.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe7/3086609/69beb07438c1/thnov01p0083g18.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe7/3086609/b135808a16f2/thnov01p0083g19.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe7/3086609/b8e081963bbc/thnov01p0083g20.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe7/3086609/f93be218ab21/thnov01p0083g21.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe7/3086609/6ee3bbf9887c/thnov01p0083g22.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe7/3086609/4967203811b5/thnov01p0083g23.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe7/3086609/e86972ac3845/thnov01p0083g24.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe7/3086609/535af52cb334/thnov01p0083g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe7/3086609/a930c8c6aab5/thnov01p0083g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe7/3086609/920be62ef5e5/thnov01p0083g06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe7/3086609/b697c2fbeac5/thnov01p0083g07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe7/3086609/345d914f8917/thnov01p0083g08.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe7/3086609/10499b4329e5/thnov01p0083g10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe7/3086609/9116ed0112fb/thnov01p0083g11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe7/3086609/da8090bc2356/thnov01p0083g12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe7/3086609/173b47df7d43/thnov01p0083g13.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe7/3086609/175b37ebf61a/thnov01p0083g14.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe7/3086609/5cbcc397ecac/thnov01p0083g15.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe7/3086609/499584d2d301/thnov01p0083g16.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe7/3086609/11d0ead164e8/thnov01p0083g17.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe7/3086609/69beb07438c1/thnov01p0083g18.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe7/3086609/b135808a16f2/thnov01p0083g19.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe7/3086609/b8e081963bbc/thnov01p0083g20.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe7/3086609/f93be218ab21/thnov01p0083g21.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe7/3086609/6ee3bbf9887c/thnov01p0083g22.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe7/3086609/4967203811b5/thnov01p0083g23.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe7/3086609/e86972ac3845/thnov01p0083g24.jpg

相似文献

1
Integrin Targeted MR Imaging.整合素靶向磁共振成像。
Theranostics. 2011 Jan 19;1:83-101. doi: 10.7150/thno/v01p0083.
2
Pushing the sensitivity envelope of lanthanide-based magnetic resonance imaging (MRI) contrast agents for molecular imaging applications.推动基于镧系元素的磁共振成像(MRI)造影剂在分子成像应用中的灵敏度极限。
Acc Chem Res. 2009 Jul 21;42(7):822-31. doi: 10.1021/ar800192p.
3
Targeted Molecular Iron Oxide Contrast Agents for Imaging Atherosclerotic Plaque.靶向分子氧化铁对比剂用于动脉粥样硬化斑块成像。
Nanotheranostics. 2020 May 30;4(4):184-194. doi: 10.7150/ntno.44712. eCollection 2020.
4
Protein-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agents: design and mechanism of action.蛋白质靶向钆基磁共振成像(MRI)造影剂:设计与作用机制
Acc Chem Res. 2009 Jul 21;42(7):851-62. doi: 10.1021/ar800220p.
5
RGD-targeted MnO nanoparticles as T contrast agents for cancer imaging - the effect of PEG length in vivo.RGD靶向的MnO纳米颗粒作为用于癌症成像的T造影剂——聚乙二醇长度在体内的影响。
J Mater Chem B. 2014 Feb 21;2(7):868-876. doi: 10.1039/c3tb21422b. Epub 2013 Dec 23.
6
Responsive MRI agents for sensing metabolism in vivo.用于体内代谢传感的响应性磁共振成像造影剂。
Acc Chem Res. 2009 Jul 21;42(7):948-57. doi: 10.1021/ar800237f.
7
Using two chemical exchange saturation transfer magnetic resonance imaging contrast agents for molecular imaging studies.使用两种化学交换饱和转移磁共振成像造影剂进行分子成像研究。
Acc Chem Res. 2009 Jul 21;42(7):915-24. doi: 10.1021/ar8002738.
8
Molecular magnetic resonance imaging of Alpha-v-Beta-3 integrin expression in tumors with ultrasound microbubbles.利用超声微泡对肿瘤中α - v - β - 3整合素表达进行分子磁共振成像。
Biomaterials. 2021 Aug;275:120896. doi: 10.1016/j.biomaterials.2021.120896. Epub 2021 May 27.
9
Molecular imaging of angiogenesis in nascent Vx-2 rabbit tumors using a novel alpha(nu)beta3-targeted nanoparticle and 1.5 tesla magnetic resonance imaging.使用新型α(nu)β3靶向纳米颗粒和1.5特斯拉磁共振成像对新生VX-2兔肿瘤中的血管生成进行分子成像。
Cancer Res. 2003 Sep 15;63(18):5838-43.
10
Dual integrin αvβ 3 and NRP-1-Targeting Paramagnetic Liposome for Tumor Early Detection in Magnetic Resonance Imaging.用于磁共振成像中肿瘤早期检测的双靶向整合素αvβ3和神经纤毛蛋白-1的顺磁性脂质体
Nanoscale Res Lett. 2018 Nov 27;13(1):380. doi: 10.1186/s11671-018-2797-6.

引用本文的文献

1
Harnessing Biomarker Activatable Probes for Early Stratification and Timely Assessment of Therapeutic Efficacy in Cancer.利用生物标志物可激活探针进行癌症的早期分层和治疗疗效的及时评估。
Exploration (Beijing). 2025 Mar 6;5(3):20240037. doi: 10.1002/EXP.20240037. eCollection 2025 Jun.
2
Magnetic Resonance Imaging and Iron-oxide Nanoparticles in the era of Personalized Medicine.磁共振成像和氧化铁纳米颗粒在个性化医疗时代。
Nanotheranostics. 2023 Aug 21;7(4):424-449. doi: 10.7150/ntno.86467. eCollection 2023.
3
D-Alpha-Tocopheryl Poly(ethylene Glycol 1000) Succinate-Coated Manganese-Zinc Ferrite Nanomaterials for a Dual-Mode Magnetic Resonance Imaging Contrast Agent and Hyperthermia Treatments.

本文引用的文献

1
Superparamagnetic nanoparticles as targeted probes for diagnostic and therapeutic applications.超顺磁纳米粒子作为靶向探针在诊断和治疗中的应用。
Dalton Trans. 2009 Aug 7(29):5583-91. doi: 10.1039/b900272n. Epub 2009 May 1.
2
Triblock copolymer coated iron oxide nanoparticle conjugate for tumor integrin targeting.三嵌段共聚物包裹的氧化铁纳米颗粒偶联物用于肿瘤整合素靶向。
Biomaterials. 2009 Dec;30(36):6912-9. doi: 10.1016/j.biomaterials.2009.08.045. Epub 2009 Sep 20.
3
The amide protons of an ytterbium(III) dota tetraamide complex act as efficient antennae for transfer of magnetization to bulk water.
用于双模式磁共振成像造影剂和热疗的聚乙二醇1000琥珀酸酯包覆的D-α-生育酚锰锌铁氧体纳米材料
Pharmaceutics. 2022 May 6;14(5):1000. doi: 10.3390/pharmaceutics14051000.
4
Modular Synthesis of Peptide-Based Single- and Multimodal Targeted Molecular Imaging Agents.基于肽的单模态和多模态靶向分子成像剂的模块化合成。
ACS Appl Bio Mater. 2021 Jul 19;4(7):5435-5448. doi: 10.1021/acsabm.1c00157. Epub 2021 Jun 4.
5
RGD-Peptide Functionalization Affects the Diffusion of a Responsive Trimeric MRI Contrast Agent through Interactions with Integrins.RGD 肽功能化通过与整合素相互作用影响响应性三聚体 MRI 对比剂的扩散。
J Med Chem. 2021 Jun 10;64(11):7565-7574. doi: 10.1021/acs.jmedchem.1c00264. Epub 2021 May 7.
6
Tracking and Quantification of Magnetically Labeled Stem Cells using Magnetic Resonance Imaging.利用磁共振成像对磁性标记干细胞进行追踪与定量分析
Adv Funct Mater. 2016 Jun 14;26(22):3899-3915. doi: 10.1002/adfm.201504444. Epub 2016 Feb 17.
7
RGD-Modified Albumin Nanoconjugates for Targeted Delivery of a Porphyrin Photosensitizer.用于卟啉光敏剂靶向递送的RGD修饰白蛋白纳米缀合物
Mol Pharm. 2017 Aug 7;14(8):2793-2804. doi: 10.1021/acs.molpharmaceut.7b00321. Epub 2017 Jul 25.
8
Targeted Dual pH-Sensitive Lipid ECO/siRNA Self-Assembly Nanoparticles Facilitate In Vivo Cytosolic sieIF4E Delivery and Overcome Paclitaxel Resistance in Breast Cancer Therapy.靶向双pH敏感脂质ECO/siRNA自组装纳米颗粒促进体内细胞溶质sieIF4E递送并克服乳腺癌治疗中的紫杉醇耐药性。
Adv Healthc Mater. 2016 Nov;5(22):2882-2895. doi: 10.1002/adhm.201600677. Epub 2016 Oct 10.
9
Gelatinase activity imaged by activatable cell-penetrating peptides in cell-based and in vivo models of stroke.在基于细胞的和体内中风模型中,通过可激活细胞穿透肽成像的明胶酶活性。
J Cereb Blood Flow Metab. 2017 Jan;37(1):188-200. doi: 10.1177/0271678X15621573. Epub 2015 Dec 17.
10
Magnetic nanoparticles and their applications in image-guided drug delivery.磁性纳米粒子及其在影像引导药物输送中的应用。
Drug Deliv Transl Res. 2012 Feb;2(1):3-21. doi: 10.1007/s13346-011-0049-8.
镱(III)多胺四酰胺配合物的酰胺质子可作为将磁化传递至大量水的有效天线。
Angew Chem Int Ed Engl. 2002 Jun 3;41(11):1919-21.
4
Polymeric nanomedicine for cancer MR imaging and drug delivery.用于癌症磁共振成像和药物递送的聚合物纳米药物
Chem Commun (Camb). 2009 Jun 28(24):3497-510. doi: 10.1039/b821865j. Epub 2009 Mar 10.
5
Symmetry-guided design and fluorous synthesis of a stable and rapidly excreted imaging tracer for (19)F MRI.用于(19)F磁共振成像的稳定且快速排泄的成像示踪剂的对称引导设计与氟相合成
Angew Chem Int Ed Engl. 2009;48(26):4755-8. doi: 10.1002/anie.200901005.
6
(68)Ga-labeled NOTA-RGD-BBN peptide for dual integrin and GRPR-targeted tumor imaging.^68^Ga 标记的 NOTA-RGD-BBN 肽用于双重整合素和 GRPR 靶向肿瘤成像。
Eur J Nucl Med Mol Imaging. 2009 Sep;36(9):1483-94. doi: 10.1007/s00259-009-1123-z. Epub 2009 Apr 10.
7
alpha4-Integrin antagonism with natalizumab: effects and adverse effects.那他珠单抗对α4整合素的拮抗作用:疗效与不良反应
J Neurol. 2008 Dec;255 Suppl 6:58-65. doi: 10.1007/s00415-008-6011-0.
8
DNAzymes to mouse beta1 integrin mRNA in vivo: targeting the tumor vasculature and retarding cancer growth.体内针对小鼠β1整合素mRNA的脱氧核酶:靶向肿瘤血管并抑制癌症生长。
Cancer Gene Ther. 2009 Sep;16(9):713-22. doi: 10.1038/cgt.2009.13. Epub 2009 Feb 27.
9
Protein-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agents: design and mechanism of action.蛋白质靶向钆基磁共振成像(MRI)造影剂:设计与作用机制
Acc Chem Res. 2009 Jul 21;42(7):851-62. doi: 10.1021/ar800220p.
10
In vivo off-resonance saturation magnetic resonance imaging of alphavbeta3-targeted superparamagnetic nanoparticles.αvβ3靶向超顺磁性纳米颗粒的体内非共振饱和磁共振成像
Cancer Res. 2009 Feb 15;69(4):1651-8. doi: 10.1158/0008-5472.CAN-08-3231. Epub 2009 Feb 3.